2008年至2012年某三甲医院门诊消化系统药物利用分析  

Analysis of Digestive System Drugs Utilization in Outpatient Department in a Grade 3A Hospital from 2008 to 2012

作　　者：吴寒寅[1] 陈静[2] 

机构地区：[1]中国人民解放军第三军医大学第三附属医院野战外科研究所药剂科,重庆400042 [2]重庆医科大学药学院

出　　处：《中国药业》2014年第16期74-76,共3页China Pharmaceuticals

摘　　要：目的了解消化系统药物的利用现状和趋势,为临床合理用药提供参考。方法调取2008年至2012年某三甲医院消化系统药物使用的相关数据,对销售金额、用药频度(DDDs)、日均费用(DDC)等数据进行统计和分析。结果消化系统药物的使用数量及销售金额逐年上升;销售金额排序前3位分别是胃酸分泌抑制药、肝胆疾病辅助用药、胃黏膜保护药;DDDs较高的为胃酸分泌抑制药、促胃肠动力药;销售金额近5年排首位的是雷贝拉唑钠;DDDs排序前10位药物的序号比基本趋近于1,DDC值较低。结论消化系统药物用量在普遍增加,且药品排序变化不大,日均用药费用较低,该院门诊用药较合理。Objective To understand the utilization status quo of digestive system drugs to provide reference for clinical rational drug use. Methods The related data of digestive system drug use in a grade 3 A hospital during 2008-2012 were extracted for conducting the statistical analysis on drug sales amount,DDDs and average daily cost （DDC）. Results The use quantity and consumption sum of digestive system drugs showed an increasing trend year by year;the top three in the consumption sum were the gastric acid secretion inhibitors,auxiliary drugs of hepatobiliary disease,gastric mucosal protective drugs;the drugs with high DDDs were gastric acid secretion inhibitors,gastrointestinal prokinetic drugs;the top drug in sales amounts in recent 5 years was rabeprazole sodium;the serial number ra- tio in top 10 drugs in DDDs ranking basically approached to 1 ,the DDC value was lower. Conclusion The use amount of digestive system drugs is generally increased,moreover the drug ranking changes little,DDC is lower,the drug use in the outpatient department is relatively rational.

关 键 词：消化系统药物 用药金额 用药频度 用药分析 

分 类 号：R975[医药卫生—药品] R969.3[医药卫生—药学]